Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)
SCTID: 1179496000, Defined, Active
1179496000|Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)|
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)
- en Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccination
- en 2019-ncov virus-like particle antigen immunisation
- en 2019-ncov virus-like particle antigen immunization
- en 2019-ncov virus-like particle antigen vaccination
- en 2019 novel coronavirus virus-like particle antigen immunisation
- en 2019 novel coronavirus virus-like particle antigen immunization
- en 2019 novel coronavirus virus-like particle antigen vaccination
- en Administration of sars-cov-2 virus-like particle antigen vaccine
- en Covid-19 virus-like particle antigen immunisation
- en Covid-19 virus-like particle antigen immunization
- en Covid-19 virus-like particle antigen vaccination
- en Sars-cov-2 virus-like particle antigen immunization
- en Sars-cov-2 virus-like particle antigen vaccination